ORPHA:90065
Acquired aneurysmal subarachnoid hemorrhage
Publications
1
8th percentile
Trials
0
Interventional, condition-specific
Researchers
5
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare, life threatening rare neurologic disease characterized by a sudden rupture of an intracranial aneurysm into the subarachnoid space. It usually presents with a sudden, severe, excruciating headache accompanied by nausea, vomiting and syncope. Other features may include focal neurological signs, third and sixth nerve palsies, and cardiac failure. Early complications include rebleeding, hydrocephalus, and .
How rare: 1-5 / 10 000 — about one to five people per ten thousand (still uncommon, but less ultra-rare).
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019543
- UMLS:C0338572
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1 matched papers (1 in last 10 years) Source
- Phenotype characterisedPresent
34 HPO annotations (e.g. Abnormal cerebral artery morphology; Hypertension; Vasospasm) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 277 for broader category subarachnoid hemorrhage
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
34
Associated phenotypes · MONDO:0019543
- Abnormal cerebral artery morphology
- Hypertension
- Vasospasm
- Cognitive impairment
- Hydrocephalus
Showing 5 of 34 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1
1 paper have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1 in the last 10 years · high confidence · 8th percentile (publications denominator)
Phrase hits: 1 · MeSH hits: 0
Who's working on it?
5
Distinct author names in 1 sampled paper — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Lehne M1 paper · 2020
Berlin Institute of Health (BIH), Berlin, Germany. moritz.lehne@bihealth.de.
Papers in Europe PMC - 02
- 03
- 04
- 05
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 277 trials are registered for subarachnoid hemorrhage, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 26 October 2026 · last trial check 26 October 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5498 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
277 interventional trials matched subarachnoid hemorrhage, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: subarachnoid hemorrhage
277
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07307508·RECRUITING·Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Randomized Controlled Trial
Conditions: Aneurysmal Subarachnoid Hemorrhage (aSAH) · Headache Disorders·Matched via name phrase
- NCT04566991·RECRUITING·Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)
Conditions: Aneurysmal Subarachnoid Hemorrhage·Matched via name phrase
- NCT06329635·RECRUITING·Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial
Conditions: Aneurysmal Subarachnoid Hemorrhage · Vasospasm·Matched via name phrase
- NCT05560373·NOT YET RECRUITING·The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study
Conditions: Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage·Matched via name phrase
- NCT06119061·RECRUITING·Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
Conditions: Subarachnoid Hemorrhage, Aneurysmal·Matched via name phrase
- NCT07493577·NOT YET RECRUITING·Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)
Conditions: Aneurysmal Subarachnoid Hemorrhage·Matched via name phrase
- NCT07642427·NOT YET RECRUITING·Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage
Conditions: Aneurysmal Subarachnoid Hemorrhage (aSAH) · Delayed Cerebral Ischemia·Matched via name phrase
- NCT07643922·NOT YET RECRUITING·Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
Conditions: Subarachnoid Hemorrhage, Aneurysmal · Cerebral Vasospasm After Subarachnoid Hemorrhage·Matched via name phrase
- NCT06409364·RECRUITING·FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Conditions: Aneurysmal Subarachnoid Hemorrhage·Matched via name phrase
- NCT07588997·RECRUITING·Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Conditions: Subarachnoid Aneurysm Hemorrhage·Matched via name phrase
- NCT04507178·RECRUITING·Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine
Conditions: Aneurysmal Subarachnoid Hemorrhage · Delayed Cerebral Ischemia·Matched via name phrase
- NCT06819657·RECRUITING·Safety , Feasibility and Preliminary Efficacy of Remote Ischemic Conditioning in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm Clipping
Conditions: Subarachnoid Hemorrhage, Aneurysmal · Cerebrovascular Disorders · Brain Diseases · Stroke·Matched via name phrase
- NCT06439615·NOT YET RECRUITING·Baricitinib for the Lung Injury Following Spontaneous SAH
Conditions: Spontaneous Subarachnoid Hemorrhage·Matched via name phrase
- NCT05095857·RECRUITING·The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
Conditions: Subarachnoid Hemorrhage, Aneurysmal · Intracerebral Hemorrhage · Traumatic Brain Injury·Matched via name phrase
- NCT04043598·RECRUITING·Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage
Conditions: Subarachnoid Hemorrhage · Critical Illness · Infusion Fluid · Sodium Disorder·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Acquired aneurysmal subarachnoid hemorrhage — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Acquired aneurysmal subarachnoid hemorrhage"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Acquired aneurysmal subarachnoid hemorrhage"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"subarachnoid hemorrhage"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T03:37:07.523Z
